The Molbio Diagnostics IPO began on 10-August-2026. It will close on 12-August-2026. The Total IPO Size is 940 Crores. The company set its IPO price at Rs 807 per share.
There are three basic categories in Molbio Diagnostics Subscription: 1) Qualified Institutional Buyers, 2) Non-Institutional Investors, and 3) Retail.
Molbio Diagnostics are an innovative point-of-care (“POC”) diagnostics company focused on expanding access to accurate, rapid and cost-effective healthcare technologies to diagnose infectious and non-communicable diseases.
They have developed their ‘Truenat’ platform, which is a novel POC polymerase chain reaction (“PCR”) platform that can operate in resource limited settings since its battery operated, facilitating decentralized diagnosis within an hour.
Molbio Diagnostics IPO Promoters
Sriram Natarajan, Chandrasekhar Bhaskaran Nair, Sangeetha Sriram, Shiva Sriram, Sowmya Sriram and Exxora Trading LLP are the promoters of the company.
Molbio Diagnostics Date, Details & Price Band
The Molbio Diagnostics Price Band, IPO Dates, Market lot and other details are mentioned in the table below.
| IPO Opening Dates | 10-August-2026 |
| IPO Closing Dates | 12-August-2026 |
| Price | 768-807 Rs |
| Fresh Issue | 200 Crores |
| Offer for sale | 740 Crores |
| Total IPO size | 940 Crores |
| Face Value | 1 INR Per Share |
| Issue Type | Book Built Issue |
| Listing On | NSE, BSE |
| Pre IPO Market Cap | 9,299.87 Cr (on Upper Price) |
Molbio Diagnostics Market Lot
The Molbio Diagnostics minimum market lot is 18 shares, with a ₹14,526 application amount.
| Lot | No of Shares | Amount | |
| Retail Minimum | 1 | 18 | ₹14,526 |
| Retail Maximum | 13 | 234 | ₹1,88,838 |
| S-HNI Minimum | 14 | 252 | ₹2,03,364 |
| S-HNI Maximum | 68 | 1,224 | ₹9,87,768 |
| B-HNI Minimum | 69 | 1,242 | ₹10,02,294 |
Restated Consolidated Financial Information (Amt. in Crore)
| Total Assets | Total Revenue | Profit After Tax | |
| 31-Mar-26 | 2,148.42 | 1,455.17 | 164.14 |
| 31-Mar-25 | 1,461.56 | 1,027.94 | 138.58 |
| 31-Mar-24 | 1,221.06 | 840.66 | 83.54 |
Molbio Diagnostics GMP & Grey Market Premium
The Molbio Diagnostics GMP (Grey Market Premium) has started today. Check the Latest Molbio Diagnostics GMP, Kostak Rates, and Subject to Sauda Price here.
Molbio Diagnostics Prospectus
The Molbio Diagnostics Prospectus is Available on the NSE/BSE and SEBI websites, as well as on our Portal. Please click here to download the Molbio Diagnostics Prospectus.
| DRHP | Download |
| RHP | Download |
| Anchor Investors List | Download |
Molbio Diagnostics Allotment Date & Details
| Allotment Date | 13-August-2026 |
| Initiation of refunds | 14-August-2026 |
| Transfer of shares to Demat accounts | 14-August-2026 |
| Listing Date | 17-August-2026 |
| Check Allotment Status | Click here |
Molbio Diagnostics Registrar
KFin Technologies Limited
Selenium, Tower B, Plot 31 – 32
Financial District, Nanakramguda,
Serilingampally Mandal
Hyderabad 500 032, Telangana, India]
Telephone: +91 40 6716 2222 / 1800 3094001
Email: molbio.ipo@kfintech.com
Investor grievance email:
einward.ris@kfintech.com
Website: www.kfintech.com
Contact person: M Murali Krishna
SEBI Registration No: INR000000221
Molbio Diagnostics Contact Address
Molbio Diagnostics Ltd
Plot No. L-46 Phase II-D,
Verna Industrial Area Verna,
Salcete South Goa, Goa,
403722
M : 8326724888
Molbio Diagnostics Lead Managers
Motilal Oswal Investment Advisors Limited
Jefferies India Private Limited
IIFL Capital Services Limited
Kotak Mahindra Capital Company Limited
